Seres Therapeutics Stock Analysis

Seres Stock Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The book value of Seres Therapeutics was now reported as 5.78. The company recorded a loss per share of 7.95. Seres Therapeutics had not issued any dividends in recent years. The entity had 1:20 split on the 22nd of April 2025. Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Seres Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 333 people. To find out more about Seres Therapeutics contact Eric MBA at 617 945 9626 or learn more at https://www.serestherapeutics.com.

Seres Therapeutics Investment Alerts

Seres Therapeutics Upcoming and Recent Events

Seres Largest EPS Surprises

View All Earnings Estimates

Seres Therapeutics Environmental, Social, and Governance (ESG) Scores

Seres Therapeutics Thematic Classifications

Seres Stock Institutional Investors

Note, although Seres Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Seres Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 122.95 M.

Seres Profitablity

Management Efficiency

Seres Therapeutics has return on total asset (ROA) of (0.2822) % which means that it has lost $0.2822 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.5628) %, meaning that it created substantial loss on money invested by shareholders. Seres Therapeutics' management efficiency ratios could be used to measure how well Seres Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Seres Therapeutics' Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0, whereas Return On Capital Employed is forecasted to decline to (1.29). At present, Seres Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 24.2 M, whereas Non Current Assets Total are forecasted to decline to about 63.1 M.

Technical Drivers

As of the 19th of July, Seres Therapeutics has the Coefficient Of Variation of 1905.08, semi deviation of 7.54, and Risk Adjusted Performance of 0.0579. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Seres Therapeutics, as well as the relationship between them.

Seres Therapeutics Price Movement Analysis

Seres Therapeutics Insider Trading Activities

Seres Therapeutics Outstanding Bonds

Seres Therapeutics Predictive Daily Indicators

Seres Therapeutics Corporate Filings

Seres Therapeutics Forecast Models

Seres Therapeutics' time-series forecasting models are one of many Seres Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Seres Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Seres Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Seres shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Seres Therapeutics. By using and applying Seres Stock analysis, traders can create a robust methodology for identifying Seres entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Seres analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Seres analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Seres Therapeutics stock analysis indicators help investors evaluate how Seres Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Seres Therapeutics shares will generate the highest return on investment. By understating and applying Seres Therapeutics stock analysis, traders can identify Seres Therapeutics position entry and exit signals to maximize returns.

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.